Adeno-associated virus enhances wild-type and oncolytic adenovirus spread

Eduardo Laborda1, Cristina Puig-Saus, Manel Cascalló

  • 11 Translational Research Laboratory, IDIBELL-Institut Català d'Oncologia , L'Hospitalet de Llobregat, 08907 Barcelona, Spain .

Human Gene Therapy Methods
|September 12, 2013
PubMed

Insights

Adeno-associated virus (AAV) contamination in adenovirus (Ad) stocks can accelerate Ad release and cell death. Coinfection enhances Ad-mediated cytotoxicity and improves antitumor activity in preclinical models, impacting Ad virotherapy.

Area of Science:

  • Virology
  • Oncolytic Virotherapy

Background:

  • Adenovirus (Ad) stocks are often contaminated with adeno-associated viruses (AAV), typically unnoticed.
  • This contamination is linked to reduced Ad yields during large-scale production and requires routine detection.

Purpose of the Study:

  • To investigate the effects of AAV coinfection on Ad propagation and efficacy.
  • To evaluate the impact of AAV coinfection on Ad-mediated cytotoxicity and antitumor activity in vivo.

Main Methods:

  • Coinfection of cell lines with Ad (wild type 5 or oncolytic) and AAV.
  • Analysis of Ad plaque phenotype, release kinetics, and cell viability.
  • Assessment of antitumor activity and survival in xenograft tumor models following intratumoral coinjection of Ad and AAV.

Main Results:

  • AAV coinfection with Ad resulted in a large-plaque phenotype and accelerated Ad release from infected cells.
  • Ad yields decreased in two of three cell lines tested, but coinfection enhanced Ad-mediated cytotoxicity and accelerated cell death.
  • Intratumoral coinjection of Ad and AAV improved antitumor activity and mouse survival in xenograft models.

Conclusions:

  • Accidental or intentional AAV coinfection significantly impacts Ad propagation and efficacy.
  • AAV coinfection enhances the therapeutic potential of Ad-mediated virotherapy by increasing cytotoxicity and improving antitumor outcomes.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...